Eli Lilly Trulicity News Today

Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish...

Denmark will start putting patients suffering from type 2 diabetes on cheaper drugs before prescribing so-called GLP-1 drugs such as Novo Nordisk's Ozempic, the Danish Medicines Agency said on Wednesday. In 2023, 50% of new patients suffering from type 2 diabetes began treatment with a reimbursed GLP-1 drug without trying a cheaper alternative first, the Medicines Agency said. Demand for Novo Nordisk's diabetes drug Ozempic has soared as many people have started using the diabetes dr...

The European Medicines Agency announced the findings of its nine-month review

By Dominic Chopping The European Unions drug regulator found no link between the class of medicines behind Novo Nordisks blockbuster Ozempic and Wegovy treatments and reports of suicidal...

The FDA earlier this year found no evidence that Ozempic and similar weight loss drugs cause suicidal thoughts or actions

Drug companies urged to ‘release stranglehold’ on medicines such as Ozempic and Trulicity, as millions are priced out of treatment

Court records show that 55 lawsuits have been filed against the companies by people who say they were prescribed the drugs but weren’t warned about severe side effects

The EUs drug watchdog will request more data from makers of a class of diabetes and weight-loss drugs including Ozempic and Wegovy to further investigate suicidal thoughts in some patients taking them.

(Reuters) -The EU's drug watchdog will request more data from makers of a class of diabetes and weight-loss drugs including Novo Nordisk's popular therapies Ozempic and Wegovy to further investigate suicidal thoughts in some patients taking them. "While at this point no conclusion can be drawn on a causal association, there are several issues that still need to be clarified," the European Medicines Agency (EMA) said in a statement on Friday, making it the first major global ...

BioPharma